MBRX – Moleculin Biotech Inc
Moleculin Biotech, Inc.MBRX
$8.06Name : Moleculin Biotech, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $8,215,470.00
EPSttm : 179.6
Moleculin Biotech, Inc.
$8.06
6.93%$0.6
MBRX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.67
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-7.13
EPS Last/This Y
503.07
EPS This/Next Y
41.93
Price
8.35
Target Price
240
Analyst Recom
1
Performance Q
-23.31
Upside
-149,861.5%
Beta
2.07
Ticker: MBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | MBRX | 0.414 | N/A | N/A | 0 |
| 2026-10-13 | MBRX | 0.4299 | N/A | N/A | 0 |
| 2026-10-14 | MBRX | 0.4108 | N/A | N/A | 0 |
| 2026-10-15 | MBRX | 0.3705 | N/A | N/A | 0 |
| 2026-10-16 | MBRX | 0.2801 | N/A | N/A | 0 |
| 2026-10-19 | MBRX | 0.264 | N/A | N/A | 0 |
| 2026-10-20 | MBRX | 6.08 | N/A | N/A | 0 |
| 2026-10-21 | MBRX | 6.27 | N/A | N/A | 0 |
| 2026-10-22 | MBRX | 5.96 | N/A | N/A | 0 |
| 2026-10-23 | MBRX | 6.33 | N/A | N/A | 0 |
| 2026-10-26 | MBRX | 7.1 | N/A | N/A | 0 |
| 2026-10-27 | MBRX | 9.29 | N/A | N/A | 0 |
| 2026-10-28 | MBRX | 8.65 | N/A | N/A | 0 |
| 2026-10-29 | MBRX | 8.83 | N/A | N/A | 0 |
| 2026-10-30 | MBRX | 8.19 | N/A | N/A | 0 |
| 2026-11-02 | MBRX | 8.31 | N/A | N/A | 0 |
| 2026-11-03 | MBRX | 8.34 | N/A | N/A | 0 |
| 2026-11-04 | MBRX | 8.455 | N/A | N/A | 0 |
| 2026-11-05 | MBRX | 8.85 | N/A | N/A | 0 |
| 2026-11-06 | MBRX | 8.88 | N/A | N/A | 0 |
| 2026-11-09 | MBRX | 8.66 | N/A | N/A | 0 |
| 2026-11-10 | MBRX | 8.35 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | MBRX | 0.42 | - | - | -3.27 |
| 2026-10-13 | MBRX | 0.43 | - | - | -3.27 |
| 2026-10-14 | MBRX | 0.41 | - | - | -3.27 |
| 2026-10-15 | MBRX | 0.37 | - | - | -3.27 |
| 2026-10-16 | MBRX | 0.28 | - | - | -3.27 |
| 2026-10-19 | MBRX | 0.27 | - | - | -3.27 |
| 2026-10-20 | MBRX | 0.27 | - | - | -3.27 |
| 2026-10-21 | MBRX | 6.14 | - | - | -3.27 |
| 2026-10-22 | MBRX | 5.89 | - | - | -3.27 |
| 2026-10-23 | MBRX | 6.50 | - | - | -3.27 |
| 2026-10-26 | MBRX | 6.80 | - | - | -65.33 |
| 2026-10-27 | MBRX | 9.21 | - | - | -65.33 |
| 2026-10-28 | MBRX | 8.75 | - | - | -65.33 |
| 2026-10-29 | MBRX | 8.85 | - | - | -65.33 |
| 2026-10-30 | MBRX | 8.11 | - | - | -65.33 |
| 2026-11-02 | MBRX | 8.33 | - | - | -65.33 |
| 2026-11-03 | MBRX | 8.28 | - | - | -65.33 |
| 2026-11-04 | MBRX | 8.38 | - | - | -65.33 |
| 2026-11-05 | MBRX | 8.84 | - | - | -65.33 |
| 2026-11-06 | MBRX | 8.88 | - | - | -65.33 |
| 2026-11-09 | MBRX | 8.92 | - | - | -65.33 |
| 2026-11-10 | MBRX | 8.35 | - | - | -65.33 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-13 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-14 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-15 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-16 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-19 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-20 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-21 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-22 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-23 | MBRX | 0.00 | 3.86 | 1.11 |
| 2026-10-26 | MBRX | 0.00 | 0 | 1.09 |
| 2026-10-27 | MBRX | 0.00 | 0 | 0.67 |
| 2026-10-28 | MBRX | 0.00 | 0 | 0.67 |
| 2026-10-29 | MBRX | 0.00 | 0 | 0.67 |
| 2026-10-30 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-02 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-03 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-05 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-06 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-09 | MBRX | 0.00 | 0 | 0.67 |
| 2026-11-10 | MBRX | 0.00 | 0 | 0.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.4
Avg. EPS Est. Current Quarter
-8.87
Avg. EPS Est. Next Quarter
-8.53
Insider Transactions
Institutional Transactions
Beta
2.07
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
16
Sentiment Score
46
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
240
P/E
Forward P/E
PEG
P/S
P/B
0.25
P/Free Cash Flow
EPS
-342.74
Average EPS Est. Cur. Y
-65.33
EPS Next Y. (Est.)
-23.4
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.44
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
-0.6
EPS 1 30Days Diff
42.8
EBIT Estimation
◆
MBRX
Healthcare
$8.01
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.7
Range 1M
74.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
88.5%
EPS NY
64.2%
52W%
2.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+2896.3% upside
Upside
+2896.3%
Quality
6
MBRX — P/E HistoricalBiotechnology
Moleculin Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 17
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
MBRX
Latest News
—
Caricamento notizie per MBRX…
stock quote shares MBRX – Moleculin Biotech Inc Stock Price stock today
news today MBRX – Moleculin Biotech Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MBRX – Moleculin Biotech Inc yahoo finance google finance
stock history MBRX – Moleculin Biotech Inc invest stock market
stock prices MBRX premarket after hours
ticker MBRX fair value insiders trading